Not Yet Recruiting
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
NCT07725796
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +20 more
- Locations
-
- East Valley Urology Center of Arizona Queen Creek, Arizona, United States
- Michael G Oefelein Clinical Trials Bakersfield, California, United States
- Urology Center of Southern California Murrieta, California, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States